| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 6, 1451-1458, Copyright © 1995 by American Society of Nephrology
REGULAR ARTICLES |
D Russo, R Minutolo, B Cianciaruso, B Memoli, G Conte and L De Nicola
Department of Nephrology, School of Medicine, I, University of Naples, Italy.
The pathophysiology and prevention of contrast media (CM)-induced nephropathy in chronic renal failure (CRF) are still ill defined. GFR, RPF, endothelin-1 (ET-1) levels, urinary sodium concentration, and fractional excretion of sodium were measured in CRF patients undergoing water diuresis in basal conditions and 20 to 120 min after an iv bolus of either the high-osmolar CM diatrizoate (D) or the low-osmolar CM iopamidol (I). The two CM induced an immediate and progressive decline of both GFR and RPF in the absence of hypovolemia, more pronounced in D (-36% at 120 min) than after I (-19% at 120 min; P < 0.05 versus D). Both CM determined a marked and steady increase of the fractional excretion of sodium. The natriuresis could not be totally ascribed to a CM-induced osmotic diuresis as because the urinary sodium concentration markedly increased. In two further groups of patients receiving D, we studied the effects of pretreatment with a single dose of either captopril or nifedipine. Both drugs, although not preventing the increase of natriuresis, partially antagonized D-induced renal hypoperfusion: GFR and RPF were equally reduced by 20% in D/captopril and D/nifedipine (P < 0.05 versus D). In unpretreated patients receiving either D or I, plasma ET-1 did not change but urinary levels increased; these changes were, however, dissociated from those observed in renal hemodynamics. Both plasma and urinary levels of ET-1 did not vary in pretreated groups. The 72-h follow-up evidenced a significant reduction of renal function only in the unpretreated D group. Therefore, the main findings after CM administration in CRF patients are: (1) an immediate GFR decline proportional to the osmolarity of CM and secondary to the renal hypoperfusion that is neither caused by hypovolemia nor mediated by ET-1, (2) an early tubular dysfunction at the level of the proximal nephron, and (3) a protective effect of single-dose pretreatment with either captopril or nifedipine on D- induced acute and short-term GFR changes.
This article has been cited by other articles:
![]() |
S. S. Brar, A. Y.-J. Shen, M. B. Jorgensen, A. Kotlewski, V. J. Aharonian, N. Desai, M. Ree, A. I. Shah, and R. J. Burchette Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial JAMA, September 3, 2008; 300(9): 1038 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pannu, N. Wiebe, M. Tonelli, and for the Alberta Kidney Disease Network Prophylaxis Strategies for Contrast-Induced Nephropathy JAMA, June 21, 2006; 295(23): 2765 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goldenberg and S. Matetzky Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies Can. Med. Assoc. J., May 24, 2005; 172(11): 1461 - 1471. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kancha, J. Lee, Z. Ahmed, A. S. Kashyap, K. P. Anand, S. Kashyap, F. Jacobs, J. P. Forman, P. Ferrari, B. Vogt, et al. Hemofiltration and the Prevention of Radiocontrast-Agent-Induced Nephropathy N. Engl. J. Med., February 19, 2004; 350(8): 836 - 838. [Full Text] [PDF] |
||||
![]() |
S. Fishbane, J. H. Durham, K. Marzo, and M. Rudnick N-Acetylcysteine In The Prevention Of Radiocontrast-Induced Nephropathy J. Am. Soc. Nephrol., February 1, 2004; 15(2): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. Curhan Prevention of Contrast Nephropathy JAMA, February 5, 2003; 289(5): 606 - 608. [Full Text] [PDF] |
||||
![]() |
P. P. Leyssac, N.-H. Holstein-Rathlou, and O. Skott Renal blood flow, early distal sodium, and plasma renin concentrations during osmotic diuresis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1268 - R1276. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673